Race, Genomics and Chronic Disease: What Patients with African Ancestry Have to Say
- PMID: 28238999
- PMCID: PMC5577001
- DOI: 10.1353/hpu.2017.0020
Race, Genomics and Chronic Disease: What Patients with African Ancestry Have to Say
Abstract
Background: Variants of the APOL1 gene increase risk for kidney failure 10-fold, and are nearly exclusively found in people with African ancestry. To translate genomic discoveries into practice, we gathered information about effects and challenges incorporating genetic risk in clinical care.
Methods: An academic-community-clinical team tested 26 adults with self-reported African ancestry for APOL1 variants, conducting in-depth interviews about patients' beliefs and attitudes toward genetic testing- before, immediately, and 30 days after receiving test results. We used constant comparative analysis of interview transcripts to identify themes.
Results: Themes included: Knowledge of genetic risk for kidney failure may motivate providers and patients to take hypertension more seriously, rather than inspiring fatalism or anxiety. Having genetic risk for a disease may counter stereotypes of Blacks as non-adherent or low-literate, rather than exacerbate stereotypes.
Conclusion: Populations most likely to benefit from genomic research can inform strategies for genetic testing and future research.
Comment in
-
Race, Genomics and Chronic Diseases: What Patients Have to Say-A Commentary.J Health Care Poor Underserved. 2017;28(1):261-265. doi: 10.1353/hpu.2017.0021. J Health Care Poor Underserved. 2017. PMID: 28239000 No abstract available.
References
-
- Xue JL, Eggers PW, Agodoa LY, et al. Longitudinal study of racial and ethnic differences in developing end- stage renal disease among aged Medicare beneficiaries. J AmSoc Nephrol. 2007 Apr;18(4):1299–306. Epub 2007 Feb 28. https://doi.org/10.1681/ASN.2006050524. - DOI - PubMed
-
- United States Renal Data System (USRDS) Bethesda, MD: National Institute of Health; 2010. USRDS 2010 Annual Data Report: atlas of chronic kidney disease and end- stage renal disease in the United States. Available at: www.usrds.org/atlas10.aspx.
-
- Peralta CA, Bibbins- Domingo K, Vittinghof E, et al. APOL1 genotype and race differences in incident albuminuria and renal function decline. J Am Soc Nephrol. 2015 Mar;27(3):887–93. Epub 2015 Jul 15. https://doi.org/10.1681/ASN.2015020124. - DOI - PMC - PubMed
-
- Johns TS, Estrella MM, Crews DC, et al. Neighborhood socioeconomic status, race, and mortality in young adult dialysis patients. J Am Soc Nephrol. 2014 Nov;25(11):2649–57. https://doi.org/10.1681/ASN.2013111207. - DOI - PMC - PubMed
-
- Norris KC, Agodoa LY. Unraveling the racial disparities associated with kidney disease. Kidney Int. 2005 Sep;68(3):914–24. https://doi.org/10.1111/j.1523-1755.2005.00485.x. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous